BioCentury This Week cover image

Ep. 120 - Next-gen NK cells, Plus Woodcock & BMS’s Russian Withdrawal

BioCentury This Week

00:00

Is There a Nero Targeted Avs?

Karen: There's definitely a broader set of modifications that are tested out at asco. Janet woodcock has transformed the way drugs are regulated, and in the process, she's changed the pathway from the lab to the bedside. All right, let's take a ride down washington metra's red line to the hamlet of silver spring, maryland. The story is on line at five centured out comets.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app